Related Experiment Video
Updated: Jun 3, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Electronic nicotine delivery systems: a research agenda
Jean-François Etter1, Chris Bullen, Andreas D Flouris
1Institute of social and preventive medicine, University of Geneva, CMU, case postale, CH-1211 Geneva 4, Switzerland. jean-francois.etter@unige.ch
Further research is needed to understand the safety and efficacy of electronic nicotine delivery systems (ENDS) for smoking cessation. Prioritizing safety studies is crucial before assessing their effectiveness as aids.
Area of Science:
- Public Health
- Toxicology
- Regulatory Science
Background:
- Electronic nicotine delivery systems (ENDS) are increasingly used, with some smokers reporting their use for smoking cessation.
- Regulatory responses to ENDS vary widely globally, lacking a strong empirical basis.
- There is a significant gap in scientific research regarding ENDS safety, abuse liability, and cessation efficacy.
Purpose of the Study:
- To identify and prioritize research needs for electronic nicotine delivery systems (ENDS).
- To inform regulatory decisions, healthcare provider recommendations, and consumer choices regarding ENDS.
- To address the dearth of scientific evidence on ENDS.
Main Methods:
- The authors, with expertise spanning basic science to public health, propose research priorities.
- Recommendations include non-clinical, clinical, and public health studies.
- Focus on characterizing the safety profile, including long-term use.
Main Results:
- The primary research priority is to establish the safety profile of ENDS.
- Efficacy as smoking cessation aids should be tested only after safety is demonstrated.
- Current marketing of ENDS represents an uncontrolled experiment with user health as the primary outcome.
Conclusions:
- Characterizing ENDS safety is the foremost research priority.
- Rigorous trials are needed to assess ENDS efficacy for smoking cessation.
- Further research can guide regulation, potentially saving lives by ensuring product safety and efficacy.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:33Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
Published on: April 12, 2022
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Oral Drug Delivery Systems: Introduction
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...